DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Lemoyne, PA

9 verified pulmonary disease doctors in Lemoyne.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Pennsylvania State Board of Medicine

Dr. Philip Carey, MD

Pulmonary Disease

21 yrs NPPES
NPI 1366435984
50 N 12TH ST, Lemoyne, PA 17043(717) 234-2561
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $29.24 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$29.24

Total received

1

Transactions

1

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$29.24

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 51th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Philip Carey do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Richard Evans, DO

Pulmonary Disease

21 yrs NPPES
NPI 1003803099
50 N 12TH ST, Lemoyne, PA 17043(717) 234-2561
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $191.27 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$191.27

Total received

7

Transactions

2

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$168.34
Boehringer Ingelheim Pharmaceuticals, Inc.$22.93

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 64th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Richard Evans do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Hiren Shingala, MD

Pulmonary Disease

19 yrs NPPES
NPI 1982722823
50 N 12TH ST, Lemoyne, PA 17043(717) 234-2561
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $76.46 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$76.46

Total received

4

Transactions

1

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$76.46

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 56th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Hiren Shingala do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Henry Ostman, MD

Pulmonary Disease

19 yrs NPPES
NPI 1851516504
50 N 12TH ST, Lemoyne, PA 17043(717) 234-2561
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $3,342 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$3,342

Total received

8

Transactions

4

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$3,231
Boehringer Ingelheim Pharmaceuticals, Inc.$80.72
Ethicon Inc.$17.17
GlaxoSmithKline, LLC.$13.11

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 89th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Henry Ostman do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Rommel Bebe, MD

Pulmonary Disease

19 yrs NPPES
NPI 1982822730
50 N 12TH ST, Lemoyne, PA 17043(717) 234-2561
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $57.36 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$57.36

Total received

3

Transactions

1

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$57.36

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 54th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Rommel Bebe do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Christopher Shaffer, MD

Pulmonary Disease

16 yrs NPPES
NPI 1598085094
50 N 12TH ST, Lemoyne, PA 17043(717) 234-2561
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $166.78 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$166.78

Total received

3

Transactions

2

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$130.35
KARL STORZ Endoscopy-America$36.43

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 63th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Christopher Shaffer do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Michael Stefanski, MD

Pulmonary Disease

16 yrs NPPES
NPI 1699086496
50 N 12TH ST, Lemoyne, PA 17043(717) 234-2561
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Joshua Hoffman, MD

Pulmonary Disease

16 yrs NPPES
NPI 1487966065
50 N 12TH ST, Lemoyne, PA 17043(717) 234-2561
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $291.73 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$291.73

Total received

10

Transactions

1

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$291.73

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 68th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Joshua Hoffman do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Brian Hirsh, MD

Pulmonary Disease

13 yrs NPPES
NPI 1235472457
50 N 12TH ST, Lemoyne, PA 17043(172) 342-5617
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Pulmonary Disease in Lemoyne, PA — Verified | DoctorsProof | DoctorsProof